Herpes Simplex Virus Infection
📧 Sign up to get email alerts when something new happens for Herpes Simplex Virus Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-10-11FDA Approved: ACYCLOVIR SODIUM — Original Application (Eugia US LLC)
FDA approved the original application for acyclovir sodium by Eugia US LLC, a generic version of acyclovir.
-
CLINICAL_TRIALS trial_result · 2013-08-22Clinical Trial Update: HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons [Phase 3]
This update reports the completion of a Phase 3 trial testing whether HSV-2 suppression lowers HIV-1 viral levels in individuals co-infected…
-
CLINICAL_TRIALS trial_result · 2013-08-22Clinical Trial Update: HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men. [Phase 3]
Phase 3 trial evaluating HSV-2 suppression to reduce HIV-1 levels in men co-infected with HIV-1 and HSV-2 has completed.
-
FDA approval · 2013-01-17FDA Approved: VALACYCLOVIR HYDROCHLORIDE — Supplemental Application (TIME CAP LABORATORIES, INC.)
FDA approved a supplemental application for valacyclovir hydrochloride from Time Cap Laboratories, Inc.
-
FDA approval · 2012-10-30FDA Approved: VALACYCLOVIR HYDROCHLORIDE — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
FDA approved a supplemental application for Valacyclovir hydrochloride submitted by Jubilant Cadista Pharmaceuticals Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-01-12FDA Approved: FAMCICLOVIR — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original ANDA for famciclovir from Macleods Pharmaceuticals Limited, establishing a generic version of the antiviral. The d…
-
FDA approval · 2011-05-09FDA Approved: FAMCICLOVIR — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for famciclovir from Teva Pharmaceuticals USA, Inc., updating the regulatory status for the generic …
-
CLINICAL_TRIALS trial_result · 2011-03-01Clinical Trial Update: Comparison of Brovavir Versus Acyclovir in the Treatment of Herpes in HIV-Infected Patients [Phase 2]
Phase 2 randomized trial comparing Brovavir to Acyclovir for herpes in HIV-infected patients has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella Pertussis
GlaxoSmithKline-sponsored seroprevalence study assessing antibodies to Hepatitis A, Varicella-zoster virus, Cytomegalovirus, Herpes simplex,…
-
CLINICAL_TRIALS research · 2011-01-13Clinical Trial Update: Prevalence of Sexually Transmitted Infections (STIs) in HIV-infected Patients
The completed observational study assesses the prevalence of sexually transmitted infections among HIV-infected patients, reporting data on …
-
CLINICAL_TRIALS trial_result · 2010-12-14Clinical Trial Update: Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex Infection [Phase 2]
Phase 2 study evaluating pharmacokinetics, acceptability, and safety of famciclovir in infants aged 1 month to less than 12 months with herp…
-
FDA approval · 2010-05-12FDA Approved: XERESE — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for XERESE, a topical product containing acyclovir and hydrocortisone, from Bausch Health US LLC…
-
CLINICAL_TRIALS trial_result · 2010-04-09Clinical Trial Update: Acyclovir for Herpes Infections Involving the Central Nervous System in Neonates [Phase 3]
A Phase 3 trial assessed acyclovir for herpes simplex infections involving the central nervous system in neonates. The study is completed an…
-
CLINICAL_TRIALS trial_result · 2009-05-06Clinical Trial Update: Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection [Phase 3]
Phase 3 pediatric trial of famciclovir for herpes simplex virus infection in children aged 1 to 12 years has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Valaciclovir to Prevent Transmission of Herpes Simplex Virus [Phase 3]
A Phase 3 trial evaluating valacyclovir to prevent transmission of herpes simplex virus has completed.
-
CLINICAL_TRIALS trial_result · 2008-01-10Clinical Trial Update: A Study of Valacyclovir to Suppress HSV and HIV Shedding in Coinfected Persons [Phase 4]
This document notes the completion of a Phase 4 clinical trial evaluating valacyclovir to suppress herpes simplex virus shedding and HIV she…
-
CLINICAL_TRIALS trial_result · 2008-01-10Clinical Trial Update: A Study of HSV Testing Among Pregnant Women [NA]
The University of Washington-sponsored study on HSV testing in pregnant women has been terminated.
-
CLINICAL_TRIALS trial_result · 2008-01-07Clinical Trial Update: 30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of Volunteers [Phase 1]
This is a 30-day Phase 1 trial evaluating valacyclovir (Valtrex) alone or with aspirin. The study assesses shedding of herpes simplex virus …
-
FDA approval · 2007-11-27FDA Approved: FOSCAVIR — Supplemental Application (Clinigen Limited)
FDA approved a supplemental application for FOSCAVIR (foscarnet sodium) submitted by Clinigen Limited, updating the drug's approval status.
-
CLINICAL_TRIALS trial_result · 2006-08-10Clinical Trial Update: A Randomized Controlled Trial of Acyclovir Among HIV and HSV-2 Co-Infected Women, Chiang Rai, Thailand [Phase 4]
A Phase 4 randomized trial evaluating acyclovir among HIV and HSV-2 co-infected women in Chiang Rai, Thailand has been completed.